Tinlorafenib (PF-07284890) (compound 10) is an orally active BRAF kinase inhibitor, with IC 50 s of 4.25 and 2.7 nM for BRAF V600E/V600K respectively. Tinlorafenib demonstrates CNS penetration and can be used in the research of BRAF -associated malignant and benign tumors of the CNS as well as extracranial malignancies.